NovaBridge Biosciences (NBP) Other Non Operating Income (2019 - 2025)
NovaBridge Biosciences (NBP) reported Other Non Operating Income of -$1.8 million for Q4 2025, down 630.3% year-over-year from $330000.0 in Q4 2024, and down 12600.0% quarter-over-quarter from $14000.0 in Q3 2025.
NovaBridge Biosciences (NBP) Other Non Operating Income (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 4 years of Other Non Operating Income data on file, last reported at -$1.8 million in Q4 2025.
- Other Non Operating Income for Q4 2025 came in at -$1.8 million, down 630.3% year-over-year; the trailing twelve-month figure through Dec 2025 was -$11.9 million (down 124.16% YoY), and the FY2025 annual result was -$1.7 million, up 64.35% from the prior year.
- Other Non Operating Income retreated to -$1.8 million in Q4 2025 per NBP's latest filing, from $14000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $330000.0 in Q4 2024 and troughed at -$10.5 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.75 Mn |
| Sep 30, 2025 | 14,000.00 |
| Dec 31, 2024 | 330,000.00 |
| Sep 30, 2024 | -10.53 Mn |
| Dec 31, 2020 | -1.21 Mn |
| Sep 30, 2020 | 60.81 Mn |
| Dec 31, 2019 | -3.12 Mn |
| Sep 30, 2019 | 207,582.85 |